"Deborah brings a wealth of experience to Everything Genetic thats particularly relevant to our business now and in the future."
North West healthcare business, Everything Genetic, has made an important appointment to its board of directors following a year of significant growth for the business.
Deborah Jones has become the company’s first chief financial officer and has been tasked with driving its growth strategy and supporting all strategic and operational initiatives across the business.
Everything Genetic, based in Nantwich in Cheshire, partners with some of the UK’s market-leading laboratories to supply revolutionary genetic tests to healthcare providers and patients for the detection, diagnosis and treatment planning of cancer, heart disease and other illnesses.
Prior to joining Everything Genetic, Deborah spent 15 years as chief financial officer for a private equity-backed technology businesses, taking them through the full investment cycle from initial management buyout, secondary buyout, to successful exit.
Deborah has significant experience in raising finance, strategic development and growing and managing successful finance teams. She qualified as a Chartered Accountant with PwC in 1995 and, two years later, moved into industry working initially as the finance director and later company secretary at the listed company, European Colour plc.
James Price, chief executive of Everything Genetic Ltd, said: “This is a pivotal and exciting appointment for our company as we welcome Deborah to our board of directors. She brings a wealth of experience to Everything Genetic that’s particularly relevant to our business now and in the future.
“After years of being a disruptive player in the genetic testing market, coupled with our launch last year of COVID-19 testing services, Everything Genetic is poised for unprecedented growth. Deborah’s business acumen, coupled with her enthusiasm, will prove instrumental as we chart an exciting path forward for our company.”
Deborah said: “I am really pleased to be joining Everything Genetic at such a busy and exciting time for the business. I look forward to working with James, the board, and my colleagues across the company, and playing my part in the future growth and success of the company.”